Wayss K, Mattern J, Volm M
Arzneimittelforschung. 1975 Jan;25(1):77-81.
The antineoplastic activity of 5 substances was tested in vivo and in vitro on four different tumours (plasmocytoma and melanoma Fortner III of the Syrian golden hamster, the Walker carcinosarkoma 256 and an adenocarcinoma of the rat). The substances involved were 2,3,5-triethyleniminobenzoquinone-(1,4) (triaziquone), actinomycin D, podophyllinic ethylhydrazide (mitopodozide), bleomycin and adriamycin hydrochloride. The effect of the substances in vivo was measured on the size of the tumour, and in vitro on the incorporation of 3-H-thymidine and 3-H-uridine in short-term incubations of tumour-cell suspensions. No correlation was observed between the 3-H-thymidine incorporation in vitro and the response of the tumours in vivo. On the other hand, the 3-H-uridine incorporation in the tumour-cell suspensions in vitro was in good agreement with the results of therapy in the animal experiments. This is compatible with the results of earlier experiments using other substances to investigate the possible correlation between tumour therapy and in vitro tests.
对5种物质的抗肿瘤活性进行了体内和体外测试,受试对象为4种不同肿瘤(叙利亚金仓鼠的浆细胞瘤和福尔特纳III型黑色素瘤、沃克癌肉瘤256以及大鼠腺癌)。所涉及的物质有2,3,5-三亚乙基亚胺苯醌-(1,4)(三嗪醌)、放线菌素D、鬼臼乙叉肼(米托泊苷)、博来霉素和盐酸阿霉素。测定了这些物质在体内对肿瘤大小的影响,以及在体外对肿瘤细胞悬液短期培养中3-H-胸腺嘧啶核苷和3-H-尿苷掺入情况的影响。未观察到体外3-H-胸腺嘧啶核苷掺入与体内肿瘤反应之间存在相关性。另一方面,体外肿瘤细胞悬液中3-H-尿苷的掺入情况与动物实验中的治疗结果高度一致。这与早期使用其他物质研究肿瘤治疗与体外测试之间可能相关性的实验结果相符。